Director/PDMR Shareholding

Summary by AI BETAClose X

The Chief Executive Officer submitted an initial PDMR disclosure that on 9 November 2026 he purchased 28 QinetiQ ordinary shares at £5.2851 per share for a total consideration of £147.98 and was awarded 9 matching shares under the QinetiQ Share Incentive Plan, an aggregate 37 shares transacted on the London Stock Exchange (XLON).

Disclaimer*

UK 100

Latest directors dealings